PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern China

por Wu, Kai-Jie, Pei, Xin-Qi, Tian, Ge, Wu, Da-Peng, Fan, Jin-Hai, Jiang, Yu-Mei, He, Da-Lin
Publicado 2018